MH
Mayur Hirjibhai Kansagara
About Mayur Hirjibhai Kansagara
Data last updated:
Mayur Hirjibhai Kansagara is a Designated Partner at Kansagara Unipath Specialty Laboratory Llp (since 2019) and Director at Silvercrest Ventures Private Limited (since 2022). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹3.43 Cr; the largest is Kansagara Unipath Specialty Laboratory Llp at ₹3.30 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 06 Nov 2019 | 2019 | ₹3.30 Cr (FY 2023) | Active | |
| Director | 02 May 2022 | 2022 | ₹12.5 Lakh (FY 2025) | Active |
Board colleagues of Mayur Hirjibhai Kansagara
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mayur Hirjibhai Kansagara
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mayur Hirjibhai Kansagara
Mayur Hirjibhai Kansagara currently holds 2 directorships: Kansagara Unipath Specialty Laboratory Llp (Designated Partner, since 06 Nov 2019, revenue ₹3.30 Cr (FY 2023)); Silvercrest Ventures Private Limited (Director, since 02 May 2022, revenue ₹12.5 Lakh (FY 2025)).
Mayur Hirjibhai Kansagara was first appointed on 06 Nov 2019 as Designated Partner at Kansagara Unipath Specialty Laboratory Llp. The most recent appointment on record is 02 May 2022 at Silvercrest Ventures Private Limited.
The 2 current companies of Mayur Hirjibhai Kansagara that report revenue have a combined latest revenue of ₹3.43 Cr: Kansagara Unipath Specialty Laboratory Llp ₹3.30 Cr (FY 2023); Silvercrest Ventures Private Limited ₹12.5 Lakh (FY 2025).
The current boards of Mayur Hirjibhai Kansagara's companies include Hirjibhai Laljibhai Kansagara (Kansagara Unipath Specialty Laboratory Llp), Jwalant Sureshbhai Shah (Kansagara Unipath Specialty Laboratory Llp), Kripali Mayur Kansagara (Kansagara Unipath Specialty Laboratory Llp), Akash Chandulal Patoliya (Silvercrest Ventures Private Limited), Chintan Maganlal Mori (Silvercrest Ventures Private Limited), Janakkumar Parsotam Dharasandiya (Silvercrest Ventures Private Limited), among others.